Lisanti Capital Growth’s Teladoc Health TDOC Stock Holding History

Lisanti Capital Growth’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-22,595	Closed	-$3.5M	–	145
2020 Q1	$3.5M	Sell	22,595 -50,276	-69%	-$5.85M	1.16%	35
2019 Q4	$6.1M	Buy	72,871 +54,231	+291%	+$4.13M	1.62%	17
2019 Q3	$1.26M	Buy	+18,640	New	+$1.23M	0.41%	74
2018 Q4	–	Sell	-39,215	Closed	-$3.39M	–	120
2018 Q3	$3.39M	Sell	39,215 -14,759	-27%	-$1.05M	1.18%	32
2018 Q2	$3.13M	Sell	53,974 -4,919	-8%	-$240K	1.2%	30
2018 Q1	$2.37M	Buy	+58,893	New	+$2.22M	1.15%	33
2017 Q3	–	Sell	-30,312	Closed	-$1.05M	–	131
2017 Q2	$1.05M	Sell	30,312 -3,018	-9%	-$87.9K	0.7%	59
2017 Q1	$833K	Buy	+33,330	New	+$693K	1.19%	34

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Lisanti Capital Growth's TDOC Position: Q2 2020 in Review

Lisanti Capital Growth sold out of Teladoc Health (TDOC) in Q2 2020, closing a stake of 22,595 shares — an estimated $3.5M sold.

Lisanti Capital Growth first reported a position in TDOC in Q1 2017 and held it in 8 quarters. The position peaked at $6.1M in Q4 2019. 670 funds tracked by Wall St. Rank hold TDOC as of Q2 2020.

Lisanti Capital Growth reported no remaining Teladoc Health position as of Q2 2020 after selling out during the quarter.
Lisanti Capital Growth sold 22,595 Teladoc Health shares in Q2 2020, an estimated $3.5M.
Lisanti Capital Growth first reported a position in Teladoc Health in Q1 2017 and held it in 8 quarters.
Lisanti Capital Growth's Teladoc Health position peaked at $6.1M in Q4 2019.
670 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2020.

Based on Lisanti Capital Growth's 13F filing for Q2 2020, filed 10 Aug 2020.